| Purinergic signaling and cochlear injury-Targeting the immune system? L Köles, J Szepesy, E Berekméri, T Zelles International journal of molecular sciences 20 (12), 2979, 2019 | 15 | 2019 |
| Purinergic signaling in the organ of Corti: Potential therapeutic targets of sensorineural hearing losses E Berekméri, J Szepesy, L Köles, T Zelles Brain Research Bulletin 151, 109-118, 2019 | 14 | 2019 |
| Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice DB Fulop, V Humli, J Szepesy, V Ott, D Reglodi, B Gaszner, A Nemeth, ... Scientific Reports 9 (1), 14598, 2019 | 9 | 2019 |
| Chronic oral selegiline treatment mitigates age-related hearing loss in BALB/c mice J Szepesy, V Humli, J Farkas, I Miklya, J Timar, T Tábi, A Gaborjan, ... International journal of molecular sciences 22 (6), 2853, 2021 | 6 | 2021 |
| Anti-PD-1 therapy does not influence hearing ability in the most sensitive frequency range, but mitigates outer hair cell loss in the basal cochlear region J Szepesy, G Miklós, J Farkas, D Kucsera, Z Giricz, A Gáborján, G Polony, ... International journal of molecular sciences 21 (18), 6701, 2020 | 5 | 2020 |
| Dose-dependent tissue distribution of K117, a bis-pyridinium aldoxime, in rats H Kalász, G Karvaly, K Musilek, K Kuca, J Young-Sik, B Malawska, ... The Open Medicinal Chemistry Journal 13 (1), 2019 | 3 | 2019 |
| Szenzorineurális halláskárosodások és lehetséges gyógyszeres terápiájuk-az immunrendszer lehetséges szerepe J Szepesy | | 2022 |
| Protective effect of rasagiline in aminoglycoside ototoxicity V Humli, G Polony, R Ando, M Aller, T Horvath, J Szepesy, A Harnos, ... ACTA PHYSIOLOGICA 211, 159-159, 2014 | | 2014 |
